[Introduction of Dr. Woojin Lee, J.D., Ph.D.]
Before starting her career as a lawyer providing legal service for Life Science and Pharmaceutical companies , Woojin earned a Ph.D. degree in Neuroscience at the University College London, Institute of Neurology, as a government scholarship recipient and a Master's degree in Oncology at the University of Nottingham,at the School of Molecular Medical Science in the U.K. Woojin is a skilled advisory lawyer sought by many Life Science and Pharmaceutical companies in South Korea, based on her in-depth experience from Life Science research in the laboratory, global clinical trials and working as an IP lawyer before opening her own specialised practice in year 2020. Woojin also has experience as a professional academic consultant in the field of English Medical Writing and has been recognized for her expertise in lectures for Medical Science Communication.
▲ J.D. at Ewha Law School, Attorney at Law, Patent Attorney (2016)
▲ Ph.D. Neuroscience at Institute of Neurology, University College London, UK (2011)
▲ M.Sc. Oncology at the School of Molecular Medical Science, The University of Nottingham, UK (2006)
▲ B.Sc. Life Science at Ewha Womans University (2004)
◆ Arbitrator (Pharma & Biotech), Korean Commercial Arbitration Board (KCAB)
◆ Expert Member, Integrated Technology Protection Support Group, Korea Commission for Corporate Partnership
◆ Member, Venture & Startup Legal Support Committee, Korean Bar Association
◆ Member, Korean Patent Attorneys Association
◆ Member, Biohealthcare Association
◆ Committee Member, Information Disclosure Review Committee, Bucheon Branch, Regional Employment and Labor Office, Ministry of Employment and Labor
◆ Committee Member, Education Committee, Incheon Bar Association
◆ Committee Member, Elder Protection Center Steering Committee, Incheon Metropolitan City
◆ Committee Member, Special Committee for Establishing an International Dispute Resolution Court, Incheon Bar Association
◆ Village Lawyer for Foreign Residents, Incheon Immigration Office
◆ Incheon Metropolitan Office of Education – Legal Support Group for the Protection of Educational Activities
◆ Graduate of Women Outside Director Program, Korea Corporate Governance Forum / Ewha Womans University | Alumni Association Member
◆ Executive Member (7th Class), Korean Government Scholarship Alumni Association (www.koreascholarship.or.kr)
◆ Host, “Legal Talk with Woojin Lee” – Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA)
- M&A Issues in Biopharma: https://youtu.be/Pwdpyq71ngY?si=MtJgt4f8e8fTeKlv
- Serious Accidents Punishment Act: https://youtu.be/vzRUgsjM5d0?si=eA5B11-dQOJF4hdC
- Biopharma Licensing Transactions: https://youtu.be/SuscTNYxBRI?si=1mDfPD2L1CduUm8g
◆ Speaker, 5th Women’s Tech Startup Forum – “The Future of AI Bio-Healthcare Women Entrepreneurs”
: https://youtu.be/8-c64b7m0rU?si=t-IBwbQvdI3jqyEg
◆ Speaker, K-BIC Venture Café with Johnson & Johnson JLABS Korea – “English Contract Review and Business Strategy for Global Expansion of Startups”
◆ Speaker, Bio-Academy (Bio i-CORE Program) – “English Contracts and Negotiation Strategies for Biopharma Companies" : https://youtu.be/4ozVAUT5Xs0?si=vRtCldvFRJnztjn4
◆ Academic Awards & Scholarships
2009-2010 University College London Research Studentship
2006-2009 Korean Government Overseas Scholarship Grant in Biological Studies for PhD studies
2002-2004 Dean’s list Sophomore, Dean’s list 1st and 2nd Semester 2002, Dean’s list 2nd Semester 2003 at Ewha Womans University
◆ Publications
· Commentary on Autonomy and Familism, W. Lee, Ewha Institute of Biomedical Law & Ethics, 2014 January
· The novel vaccine peptide GV1001 effectively blocks ß-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase. Park, H.-H., Lee K.-Y., Kim S., Lee W. et al. Neurobiology of Aging (2014)
· Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Morsali D, Bechtold D, Lee W et al., Brain 2013;136(Pt4):1067-82
· Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T cell proliferation. Sajic M, Hunt DP, Lee W et al., PLoS One 2012;(7):e30708. Epub 2012 Feb 16.
[Legal Expertise and Service]
◆ Biopharma·Life Science Collaborations & Clinical trials
◆ Intellectual Property, Licensing & Transactions
◆ Corporate Services & Strategic Counseling
· Confidentiality, Joint Research and Development Agreements, Research Service Contracts
· Research Service Contracts
· Clinical Trial Agreement (CTA)
· Clinical Trial Service (MSA) and C(D)MO production contracts
· Material Transfer Agreement (MTA)
· Technology Transfer Agreements
· Consultant/Expert Agreements
· Safety Information Exchange Agreements
· Venture Investment Agreements
· Intellectual Property Transfer/Assignment and Licensing Agreements (Patents/Trademarks)
· Other Corporate Legal Affairs related to strategic IPOs of venture Life Science or Biopharmaceutical companies
· English contracts for civil commercial transactions for pharmaceutical and bio companies
[Contact Information]
Email: mail@woojinleelaw.com
Tel & Office : 82(0)32-833-1217 / #1705 Songdo Centroad A, 323 Incheon tower-daero, Yeonsu-gu, Incheon, Republic of Korea, 22007
Homepage : www.woojinleelaw.com (Korean)
LinkedIn: https://www.linkedin.com/in/woojinleelawyer/
Instagram: https://www.instagram.com/woojinleelaw_korean_lawyer/
Youtube: https://www.youtube.com/channel/UC9zlqcalZ_cOBgx8j0k28zw
#English speaking Korean Lawyer #Life Science Laywer in Korea # Biopharmaceutical Lawyer in Korea #Law Office of Woojin Lee #Woojin Lee #Korean Lawyer